glp-1 news september 26 2025 Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society The New Health Consumer Mindset

Traditional insurance models work on the assumption that expensive medications serve a relatively small percentage of members

Giorgino, GLP-1 receptor agonists for cardiovascular protection: a matter of time

Advances in the pathogenesis of psoriasis: from keratinocyte perspective

This update underscores both the promise and the complexity of advancing oral GLP-1 drug technology, highlighting ongoing industry efforts to balance innovation, safety and patient-centric design as companies work to meet evolving global treatment needs

Regardless of blood sugar level. This is both their strength and their biggest weakness

These medications work best when paired with healthy eating and healty life style